We are live on ! Find out more
TCON

TRACON Pharmaceuticals

Delisted

TCON was delisted on the 27th of June, 2024.

26 hedge funds and large institutions have $18.7M invested in TRACON Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

151% more capital inflows, than outflows

Capital inflows: $3.43M | Capital outflows: $1.37M

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

2.51% more ownership

Funds ownership: 31.55% → 34.05% (+2.5%)

0% more funds holding

Funds holding: 26 → 26 (0)

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TCON Hedge Fund Activity: Q3 2017 in Review

26 of the 4,024 institutional investors tracked by Wall St. Rank reported a position in TRACON Pharmaceuticals (TCON) for Q3 2017, worth a combined $18.7M — up 49% from $12.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TCON positions and 6 closed out — a net gain of 2 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $2.59M. The largest seller was Franklin Resources, exiting entirely with an estimated $1.09M sold.

  • 26 institutional investors held TRACON Pharmaceuticals (TCON) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $18.7M of TRACON Pharmaceuticals stock for Q3 2017, up 49% quarter-over-quarter.
  • 8 funds opened new TRACON Pharmaceuticals positions in Q3 2017 and 6 closed out, a net change of +2 holders.
  • The largest TRACON Pharmaceuticals buyer in Q3 2017 was 683 Capital Management, an estimated $2.59M added.
  • The largest TRACON Pharmaceuticals seller in Q3 2017 was Franklin Resources, an estimated $1.09M sold.

Based on aggregated 13F filings for Q3 2017.